Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Oncology
Multiple Myeloma
,
Oncology
Multiple Myeloma Treatments Are Moving Rapidly from Bench to Bedside
Wayne Kuznar
Read More
Lung Cancer
,
Oncology
Maintenance with Pemetrexed Extends Progression-Free Survival in Advanced Nonsquamous NSCLC
Read More
Leukemia
,
Oncology
High-Dose Methotrexate Improves Survival in High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia
Read More
Multiple Myeloma
,
Oncology
Investigational Regimens with Bortezomib for Multiple Myeloma
Read More
Melanoma
,
Oncology
Novel Agents Boost Survival in Metastatic Melanoma
Audrey Andrews
Read More
Breast Cancer
,
Oncology
Regional Lymph Node Irradiation Indicated for Early Breast Cancer
Read More
Breast Cancer
,
Oncology
Exemestane: New Option for Breast Cancer Prevention
Read More
Leukemia
,
Oncology
Bosutinib Shows Superior Results in CML
Neil Canavan
,
Neil Canavan
Read More
Leukemia
,
Oncology
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Caroline Helwick
,
Caroline Helwick
,
Caroline Helwick
Read More
Multiple Myeloma
,
Multiple Myeloma
,
Oncology
VISTA Final Analysis Upholds Survival Benefit of Bortezomib at 5 Years
Caroline Helwick
,
Caroline Helwick
Read More
1
2
3
4
Page 1 of 27
Results 1 - 10 of 262